Lilly Stock Heading $1,000? What Investors Should Know
Investors are watching Eli Lilly as GLP-1 drugs like Mounjaro and Zepbound power growth. This article breaks down the...
Shifting funds with limited resources requires thoughtful prioritization. This intro provides practical tips to optimize your remaining dollars.
25,048 articlesInvestors are watching Eli Lilly as GLP-1 drugs like Mounjaro and Zepbound power growth. This article breaks down the...
A single fund's exit from Klaviyo set off a ripple effect that shaved a chunk from the stock after earnings. This art...
After a challenging stretch, small-cap stocks may be poised for a revival in 2026. This guide breaks down the signals...
Susquehanna lifts Cloudflare to a $200 price target as the AI-first reset takes shape. The stock sits near $196 after...
EMB holds near the high end of its range as volatility fades, but a shift in the 10-year yield, policy signals, or EM...
A new wave of proptech bundling is reshaping mortgage workflows. Real estate tech started with simplification, but to...
Oklo faces a pivotal Q1 2026 earnings night as it pivots from regulatory progress to early commercial milestones. Wat...
As the S&P 500 pushes higher, questions swirl about whether does michael burry know something the market isn’t pricin...
Mungo Homes has named Ric Rojas president of its newly formed Mid-Atlantic region, a move designed to accelerate grow...
USA Rare Earth is set to publish its Q1 2026 results after market close as investors await production updates and the...
Rising fuel costs collide with a blunt political remark, triggering market signals as investors assess the impact on ...
MercadoLibre reports a robust Q1 2026 with revenue rising sharply, even as margins compress. Analysts increasingly vi...